The Mortality Rate

Also known as: Deaths / Mortality / All-cause Mortality / Death / Mortalities / O/E - dead / Death NOS

DrugDrug NameDrug Description
DB00945Acetylsalicylic acidAlso known as _Aspirin_, acetylsalicylic acid (ASA) is a commonly used drug for the treatment of pain and fever due to various causes. Acetylsalicylic acid has both anti-inflammatory and antipyretic effects. This drug also inhibits platelet aggregation and is used in the prevention of blood clots stroke, and myocardial infarction (MI) [FDA label]. Interestingly, the results of various studies have demonstrated that long-term use of acetylsalicylic acid may decrease the risk of various cancers, including colorectal, esophageal, breast, lung, prostate, liver and skin cancer [A177325]. Aspirin is classified as a _non-selective cyclooxygenase (COX) inhibitor_ [A32682, A177268] and is available in many doses and forms, including chewable tablets, suppositories, extended release formulations, and others [L5968]. Acetylsalicylic acid is a very common cause of accidental poisoning in young children. It should be kept out of reach from young children, toddlers, and infants [FDA label].
DB00175PravastatinPravastatin is the 6-alpha-hydroxy acid form of [mevastatin].[T303] Pravastatin was firstly approved in 1991 becoming the second available statin in the United States. It was the first statin administered as the active form and not as a prodrug.[T274] This drug was developed by Sankyo Co. Ltd.; however, the first approved pravastatin product was developed by Bristol Myers Squibb and FDA approved in 1991.[L6142] Pravastatin is made through a fermentation process in which [mevastatin] is first obtained. The manufacturing process is followed by the hydrolysis of the lactone group and the biological hydroxylation with _Streptomyces carbophilus_ to introduce the allylic 6-alcohol group.[T239]
DB00177ValsartanValsartan is an angiotensin-receptor blocker (ARB) that may be used to manage hypertension and heart failure. Many studies have demonstrated the efficacy of valsartan in reducing blood pressure (BP) in many patient populations (including elderly, women, children, obese patients, patients with diabetes mellitus, patients with chronic kidney disease (CKD), patients at high risk of cardiovascular (CV) disease, African Americans, Hispanic Americans and Asians) and in improving the clinical outcome in cardiovascular (CV) disease and chronic kidney disease (CKD) [A174124]. Valsartan was initially approved in 1996 in Europe for the treatment of hypertension in adults. Shortly after, in 1997, this drug was approved in the United States [A174124]. This drug is generally well-tolerated with a side-effect profile superior to that of other antihypertensive drugs [A174130], [A174133].
DrugDrug NameTargetType
DB00945Acetylsalicylic acidProstaglandin G/H synthase 1target
DB00945Acetylsalicylic acidProstaglandin G/H synthase 2target
DB00945Acetylsalicylic acidAldo-keto reductase family 1 member C1target
DB00945Acetylsalicylic acidSolute carrier family 22 member 6transporter
DB00945Acetylsalicylic acidMultidrug resistance protein 1transporter
DB00945Acetylsalicylic acidCytochrome P450 2C19enzyme
DB00945Acetylsalicylic acidCytochrome P450 2C9enzyme
DB00945Acetylsalicylic acid5'-AMP-activated protein kinasetarget
DB00945Acetylsalicylic acidEndothelin-1 receptortarget
DB00945Acetylsalicylic acidNuclear factor kappa b beta subunittarget
DB00945Acetylsalicylic acidCellular tumor antigen p53target
DB00945Acetylsalicylic acid78 kDa glucose-regulated proteintarget
DB00945Acetylsalicylic acidRibosomal protein S6 kinase alpha-3target
DB00945Acetylsalicylic acidNF-kappa-B inhibitor alphatarget
DB00945Acetylsalicylic acidTumor necrosis factor-inducible gene 6 proteintarget
DB00945Acetylsalicylic acidCaspase-1target
DB00945Acetylsalicylic acidCaspase-3target
DB00945Acetylsalicylic acidInhibitor of nuclear factor kappa-B kinase subunit betatarget
DB00945Acetylsalicylic acidExtracellular signal-regulated kinase (ERK)target
DB00945Acetylsalicylic acidG1/S-specific cyclin-D1target
DB00945Acetylsalicylic acidMyc proto-oncogene proteintarget
DB00945Acetylsalicylic acidProliferating cell nuclear antigentarget
DB00945Acetylsalicylic acidCyclin Atarget
DB00945Acetylsalicylic acidUDP-glucuronosyltransferase 1-6enzyme
DB00945Acetylsalicylic acidArylamine N-acetyltransferase 2enzyme
DB00945Acetylsalicylic acidSolute carrier family 22 member 8transporter
DB00175Pravastatin3-hydroxy-3-methylglutaryl-coenzyme A reductasetarget
DB00175PravastatinSolute carrier organic anion transporter family member 2B1transporter
DB00175PravastatinMultidrug resistance protein 1transporter
DB00175PravastatinSolute carrier organic anion transporter family member 1A2transporter
DB00175PravastatinSolute carrier family 22 member 6transporter
DB00175PravastatinSolute carrier family 22 member 8transporter
DB00175PravastatinCanalicular multispecific organic anion transporter 1transporter
DB00175PravastatinSolute carrier family 22 member 11transporter
DB00175PravastatinATP-binding cassette sub-family G member 2transporter
DB00175PravastatinSolute carrier family 22 member 7transporter
DB00175PravastatinSolute carrier organic anion transporter family member 1B1transporter
DB00175PravastatinMonocarboxylate transporter 1transporter
DB00175PravastatinBile salt export pumptransporter
DB00175PravastatinSolute carrier organic anion transporter family member 1B3transporter
DB00177ValsartanType-1 angiotensin II receptortarget
DB00177ValsartanCytochrome P450 2C9enzyme
DB00177ValsartanSolute carrier organic anion transporter family member 1B3transporter
DB00177ValsartanSolute carrier organic anion transporter family member 1B1transporter
DB00177ValsartanCanalicular multispecific organic anion transporter 1transporter
DrugDrug NamePhaseStatusCount
DB00733Pralidoxime1Completed1
DB00470Dronabinol2Not Yet Recruiting1
DB00742Mannitol2Completed1
DB05034Ularitide2Completed1
DB00126Ascorbic acid2 / 3Completed1
DB00169Cholecalciferol2 / 3Completed1
DB00115Cyanocobalamin2 / 3Completed1
DB00158Folic Acid2 / 3Completed1
DB00741Hydrocortisone2 / 3Unknown Status1
DB02701Nicotinamide2 / 3Completed1
DB00165Pyridoxine2 / 3Completed1
DB00140Riboflavin2 / 3Completed1
DB00152Thiamine2 / 3Completed1
DB00162Vitamin A2 / 3Completed1
DB01211Clarithromycin3Recruiting1
DB04899Nesiritide3Unknown Status1
DB09145Water3Recruiting1
DB11248Zinc gluconate3Completed1
DB00207Azithromycin4Recruiting1
DB12768BCG vaccine4Recruiting1
DB00169Cholecalciferol4Recruiting1
DB00633Dexmedetomidine4Completed2
DB09153Sodium chloride4Completed1
DB09153Sodium chloride4Recruiting1
DB00162Vitamin A4Completed3
DB00162Vitamin A4Terminated1
DB00162Vitamin A4Unknown Status1
DB047895-methyltetrahydrofolic acidNot AvailableCompleted1
DB06605ApixabanNot AvailableCompleted2
DB13152Coagulation Factor IX HumanNot AvailableRecruiting1
DB06695Dabigatran etexilateNot AvailableCompleted2
DB00633DexmedetomidineNot AvailableActive Not Recruiting1
DB00736EsomeprazoleNot AvailableUnknown Status1
DB00158Folic AcidNot AvailableCompleted1
DB01024Mycophenolic acidNot AvailableNot Yet Recruiting1
DB06228RivaroxabanNot AvailableCompleted2
DB09153Sodium chlorideNot AvailableActive Not Recruiting1
DB00864TacrolimusNot AvailableNot Yet Recruiting1
DB00302Tranexamic acidNot AvailableUnknown Status1
DB00682WarfarinNot AvailableCompleted1
DB01593ZincNot AvailableCompleted2